HEADER TRANSFERASE 06-AUG-08 3E37 TITLE PROTEIN FARNESYLTRANSFERASE COMPLEXED WITH BISUBSTRATE ETHYLENEDIAMINE TITLE 2 SCAFFOLD INHIBITOR 5 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN FARNESYLTRANSFERASE/GERANYLGERANYLTRANSFERASE TYPE- COMPND 3 1 SUBUNIT ALPHA; COMPND 4 CHAIN: A; COMPND 5 SYNONYM: CAAX FARNESYLTRANSFERASE SUBUNIT ALPHA, RAS PROTEINS COMPND 6 PRENYLTRANSFERASE ALPHA, FTASE-ALPHA, TYPE I PROTEIN GERANYL- COMPND 7 GERANYLTRANSFERASE SUBUNIT ALPHA, GGTASE-I-ALPHA; COMPND 8 EC: 2.5.1.58, 2.5.1.59; COMPND 9 ENGINEERED: YES; COMPND 10 MOL_ID: 2; COMPND 11 MOLECULE: PROTEIN FARNESYLTRANSFERASE SUBUNIT BETA; COMPND 12 CHAIN: B; COMPND 13 SYNONYM: FTASE-BETA, CAAX FARNESYLTRANSFERASE SUBUNIT BETA, RAS COMPND 14 PROTEINS PRENYLTRANSFERASE BETA; COMPND 15 EC: 2.5.1.58; COMPND 16 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: FNTA; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: FNTB; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS FTASE, FARNESYLTRANSFERASE, PROTEIN FARNESYLTRANSFERASE, MALARIA, KEYWDS 2 PLASMODIUM, FALCIPARUM, ETHYLENEDIAMINE, PRENYLTRANSFERASE, KEYWDS 3 TRANSFERASE, METAL-BINDING, PHOSPHOPROTEIN, ZINC EXPDTA X-RAY DIFFRACTION AUTHOR M.A.HAST,L.S.BEESE REVDAT 3 21-FEB-24 3E37 1 HETSYN REVDAT 2 29-JUL-20 3E37 1 COMPND REMARK HET HETNAM REVDAT 2 2 1 FORMUL LINK SITE ATOM REVDAT 1 10-MAR-09 3E37 0 JRNL AUTH M.A.HAST,S.FLETCHER,C.G.CUMMINGS,E.E.PUSATERI, JRNL AUTH 2 M.A.BLASKOVICH,K.RIVAS,M.H.GELB,W.C.VAN VOORHIS,S.M.SEBTI, JRNL AUTH 3 A.D.HAMILTON,L.S.BEESE JRNL TITL STRUCTURAL BASIS FOR BINDING AND SELECTIVITY OF ANTIMALARIAL JRNL TITL 2 AND ANTICANCER ETHYLENEDIAMINE INHIBITORS TO PROTEIN JRNL TITL 3 FARNESYLTRANSFERASE. JRNL REF CHEM.BIOL. V. 16 181 2009 JRNL REFN ISSN 1074-5521 JRNL PMID 19246009 JRNL DOI 10.1016/J.CHEMBIOL.2009.01.014 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.4.0077 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 42.84 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 3 NUMBER OF REFLECTIONS : 101393 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.169 REMARK 3 R VALUE (WORKING SET) : 0.168 REMARK 3 FREE R VALUE : 0.190 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 5326 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.85 REMARK 3 REFLECTION IN BIN (WORKING SET) : 7115 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 93.67 REMARK 3 BIN R VALUE (WORKING SET) : 0.2430 REMARK 3 BIN FREE R VALUE SET COUNT : 361 REMARK 3 BIN FREE R VALUE : 0.2460 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5911 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 67 REMARK 3 SOLVENT ATOMS : 729 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.093 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.090 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.056 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.762 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.961 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.953 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 6137 ; 0.009 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 8345 ; 1.167 ; 1.961 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 723 ; 4.775 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 313 ;33.587 ;24.089 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1018 ;12.157 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 40 ;15.648 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 890 ; 0.081 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4735 ; 0.005 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3618 ; 0.651 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5839 ; 1.298 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2519 ; 2.086 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2506 ; 3.552 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3E37 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-AUG-08. REMARK 100 THE DEPOSITION ID IS D_1000048817. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-APR-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 101393 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.2 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.7 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 61.28 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.18 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: AMMONIUM ACETATE PH 5.2, 12% PEG8000, REMARK 280 DTT, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 290K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 21.50333 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 43.00667 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 32.25500 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 53.75833 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 10.75167 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7300 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 29020 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -15.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 ALA A 3 REMARK 465 THR A 4 REMARK 465 GLU A 5 REMARK 465 GLY A 6 REMARK 465 VAL A 7 REMARK 465 GLY A 8 REMARK 465 GLU A 9 REMARK 465 ALA A 10 REMARK 465 ALA A 11 REMARK 465 GLN A 12 REMARK 465 GLY A 13 REMARK 465 GLY A 14 REMARK 465 GLU A 15 REMARK 465 PRO A 16 REMARK 465 GLY A 17 REMARK 465 GLN A 18 REMARK 465 PRO A 19 REMARK 465 ALA A 20 REMARK 465 GLN A 21 REMARK 465 PRO A 22 REMARK 465 PRO A 23 REMARK 465 PRO A 24 REMARK 465 GLN A 25 REMARK 465 PRO A 26 REMARK 465 HIS A 27 REMARK 465 PRO A 28 REMARK 465 PRO A 29 REMARK 465 PRO A 30 REMARK 465 PRO A 31 REMARK 465 GLN A 32 REMARK 465 GLN A 33 REMARK 465 GLN A 34 REMARK 465 HIS A 35 REMARK 465 LYS A 36 REMARK 465 GLU A 37 REMARK 465 GLU A 38 REMARK 465 MET A 39 REMARK 465 ALA A 40 REMARK 465 ALA A 41 REMARK 465 GLU A 42 REMARK 465 ALA A 43 REMARK 465 GLY A 44 REMARK 465 GLU A 45 REMARK 465 ALA A 46 REMARK 465 VAL A 47 REMARK 465 ALA A 48 REMARK 465 SER A 49 REMARK 465 PRO A 50 REMARK 465 MET A 51 REMARK 465 ASP A 52 REMARK 465 ASP A 53 REMARK 465 GLY A 54 REMARK 465 GLU A 370 REMARK 465 ASN A 371 REMARK 465 ASP A 372 REMARK 465 SER A 373 REMARK 465 PRO A 374 REMARK 465 THR A 375 REMARK 465 ASN A 376 REMARK 465 VAL A 377 REMARK 465 GLN A 378 REMARK 465 GLN A 379 REMARK 465 MET B 3 REMARK 465 ALA B 4 REMARK 465 SER B 5 REMARK 465 PRO B 6 REMARK 465 SER B 7 REMARK 465 SER B 8 REMARK 465 PHE B 9 REMARK 465 THR B 10 REMARK 465 TYR B 11 REMARK 465 TYR B 12 REMARK 465 CYS B 13 REMARK 465 PRO B 14 REMARK 465 PRO B 15 REMARK 465 SER B 16 REMARK 465 GLU B 427 REMARK 465 LEU B 428 REMARK 465 LYS B 429 REMARK 465 ASP B 430 REMARK 465 GLU B 431 REMARK 465 THR B 432 REMARK 465 SER B 433 REMARK 465 ALA B 434 REMARK 465 GLU B 435 REMARK 465 PRO B 436 REMARK 465 ALA B 437 REMARK 465 THR B 438 REMARK 465 ASP B 439 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O THR A 369 O HOH B 2864 2444 2.03 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 88 47.31 34.77 REMARK 500 LEU A 215 56.89 -103.17 REMARK 500 THR A 247 -87.69 -110.95 REMARK 500 GLU A 347 -54.42 -128.83 REMARK 500 ASP A 349 52.33 -149.99 REMARK 500 ASN B 67 -122.33 49.65 REMARK 500 ASP B 322 109.98 -57.61 REMARK 500 SER B 328 -18.97 -143.62 REMARK 500 MET B 331 49.95 -85.92 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B1001 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ED5 B 1 NBC REMARK 620 2 ASP B 299 OD1 90.4 REMARK 620 3 ASP B 299 OD2 141.3 56.9 REMARK 620 4 CYS B 301 SG 116.0 104.8 94.0 REMARK 620 5 HIS B 364 NE2 96.9 128.8 90.2 116.5 REMARK 620 N 1 2 3 4 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1SA4 RELATED DB: PDB REMARK 900 RELATED ID: 1SA5 RELATED DB: PDB REMARK 900 RELATED ID: 2IEJ RELATED DB: PDB REMARK 900 RELATED ID: 1KZO RELATED DB: PDB REMARK 900 RELATED ID: 1KZP RELATED DB: PDB REMARK 900 RELATED ID: 1D8D RELATED DB: PDB REMARK 900 RELATED ID: 3E30 RELATED DB: PDB REMARK 900 FARNESYLTRANSFERASE COMPLEXED WITH FPP AND ETHYLENE DIAMINE REMARK 900 INHIBITOR 4 REMARK 900 RELATED ID: 3E32 RELATED DB: PDB REMARK 900 FARNESYLTRANSFERASE COMPLEXED WITH FPP AND ETHYLENEDIAMINE SCAFFOLD REMARK 900 INHIBITOR 2 REMARK 900 RELATED ID: 3E33 RELATED DB: PDB REMARK 900 FARNESYLTRANSFERASE COMPLEXED WITH FPP AND ETHYLENEDIAMINE SCAFFOLD REMARK 900 INHIBITOR 7 REMARK 900 RELATED ID: 3E34 RELATED DB: PDB REMARK 900 FARNESYLTRANSFERASE COMPLEXED WITH FPP AND ETHYLENEDIAMINE-SCAFFOLD REMARK 900 INHIBITOR 10 DBREF 3E37 A 1 379 UNP P49354 FNTA_HUMAN 1 379 DBREF 3E37 B 3 439 UNP P49356 FNTB_HUMAN 1 437 SEQRES 1 A 379 MET ALA ALA THR GLU GLY VAL GLY GLU ALA ALA GLN GLY SEQRES 2 A 379 GLY GLU PRO GLY GLN PRO ALA GLN PRO PRO PRO GLN PRO SEQRES 3 A 379 HIS PRO PRO PRO PRO GLN GLN GLN HIS LYS GLU GLU MET SEQRES 4 A 379 ALA ALA GLU ALA GLY GLU ALA VAL ALA SER PRO MET ASP SEQRES 5 A 379 ASP GLY PHE VAL SER LEU ASP SER PRO SER TYR VAL LEU SEQRES 6 A 379 TYR ARG ASP ARG ALA GLU TRP ALA ASP ILE ASP PRO VAL SEQRES 7 A 379 PRO GLN ASN ASP GLY PRO ASN PRO VAL VAL GLN ILE ILE SEQRES 8 A 379 TYR SER ASP LYS PHE ARG ASP VAL TYR ASP TYR PHE ARG SEQRES 9 A 379 ALA VAL LEU GLN ARG ASP GLU ARG SER GLU ARG ALA PHE SEQRES 10 A 379 LYS LEU THR ARG ASP ALA ILE GLU LEU ASN ALA ALA ASN SEQRES 11 A 379 TYR THR VAL TRP HIS PHE ARG ARG VAL LEU LEU LYS SER SEQRES 12 A 379 LEU GLN LYS ASP LEU HIS GLU GLU MET ASN TYR ILE THR SEQRES 13 A 379 ALA ILE ILE GLU GLU GLN PRO LYS ASN TYR GLN VAL TRP SEQRES 14 A 379 HIS HIS ARG ARG VAL LEU VAL GLU TRP LEU ARG ASP PRO SEQRES 15 A 379 SER GLN GLU LEU GLU PHE ILE ALA ASP ILE LEU ASN GLN SEQRES 16 A 379 ASP ALA LYS ASN TYR HIS ALA TRP GLN HIS ARG GLN TRP SEQRES 17 A 379 VAL ILE GLN GLU PHE LYS LEU TRP ASP ASN GLU LEU GLN SEQRES 18 A 379 TYR VAL ASP GLN LEU LEU LYS GLU ASP VAL ARG ASN ASN SEQRES 19 A 379 SER VAL TRP ASN GLN ARG TYR PHE VAL ILE SER ASN THR SEQRES 20 A 379 THR GLY TYR ASN ASP ARG ALA VAL LEU GLU ARG GLU VAL SEQRES 21 A 379 GLN TYR THR LEU GLU MET ILE LYS LEU VAL PRO HIS ASN SEQRES 22 A 379 GLU SER ALA TRP ASN TYR LEU LYS GLY ILE LEU GLN ASP SEQRES 23 A 379 ARG GLY LEU SER LYS TYR PRO ASN LEU LEU ASN GLN LEU SEQRES 24 A 379 LEU ASP LEU GLN PRO SER HIS SER SER PRO TYR LEU ILE SEQRES 25 A 379 ALA PHE LEU VAL ASP ILE TYR GLU ASP MET LEU GLU ASN SEQRES 26 A 379 GLN CYS ASP ASN LYS GLU ASP ILE LEU ASN LYS ALA LEU SEQRES 27 A 379 GLU LEU CYS GLU ILE LEU ALA LYS GLU LYS ASP THR ILE SEQRES 28 A 379 ARG LYS GLU TYR TRP ARG TYR ILE GLY ARG SER LEU GLN SEQRES 29 A 379 SER LYS HIS SER THR GLU ASN ASP SER PRO THR ASN VAL SEQRES 30 A 379 GLN GLN SEQRES 1 B 437 MET ALA SER PRO SER SER PHE THR TYR TYR CYS PRO PRO SEQRES 2 B 437 SER SER SER PRO VAL TRP SER GLU PRO LEU TYR SER LEU SEQRES 3 B 437 ARG PRO GLU HIS ALA ARG GLU ARG LEU GLN ASP ASP SER SEQRES 4 B 437 VAL GLU THR VAL THR SER ILE GLU GLN ALA LYS VAL GLU SEQRES 5 B 437 GLU LYS ILE GLN GLU VAL PHE SER SER TYR LYS PHE ASN SEQRES 6 B 437 HIS LEU VAL PRO ARG LEU VAL LEU GLN ARG GLU LYS HIS SEQRES 7 B 437 PHE HIS TYR LEU LYS ARG GLY LEU ARG GLN LEU THR ASP SEQRES 8 B 437 ALA TYR GLU CYS LEU ASP ALA SER ARG PRO TRP LEU CYS SEQRES 9 B 437 TYR TRP ILE LEU HIS SER LEU GLU LEU LEU ASP GLU PRO SEQRES 10 B 437 ILE PRO GLN ILE VAL ALA THR ASP VAL CYS GLN PHE LEU SEQRES 11 B 437 GLU LEU CYS GLN SER PRO GLU GLY GLY PHE GLY GLY GLY SEQRES 12 B 437 PRO GLY GLN TYR PRO HIS LEU ALA PRO THR TYR ALA ALA SEQRES 13 B 437 VAL ASN ALA LEU CYS ILE ILE GLY THR GLU GLU ALA TYR SEQRES 14 B 437 ASP ILE ILE ASN ARG GLU LYS LEU LEU GLN TYR LEU TYR SEQRES 15 B 437 SER LEU LYS GLN PRO ASP GLY SER PHE LEU MET HIS VAL SEQRES 16 B 437 GLY GLY GLU VAL ASP VAL ARG SER ALA TYR CYS ALA ALA SEQRES 17 B 437 SER VAL ALA SER LEU THR ASN ILE ILE THR PRO ASP LEU SEQRES 18 B 437 PHE GLU GLY THR ALA GLU TRP ILE ALA ARG CYS GLN ASN SEQRES 19 B 437 TRP GLU GLY GLY ILE GLY GLY VAL PRO GLY MET GLU ALA SEQRES 20 B 437 HIS GLY GLY TYR THR PHE CYS GLY LEU ALA ALA LEU VAL SEQRES 21 B 437 ILE LEU LYS ARG GLU ARG SER LEU ASN LEU LYS SER LEU SEQRES 22 B 437 LEU GLN TRP VAL THR SER ARG GLN MET ARG PHE GLU GLY SEQRES 23 B 437 GLY PHE GLN GLY ARG CYS ASN LYS LEU VAL ASP GLY CYS SEQRES 24 B 437 TYR SER PHE TRP GLN ALA GLY LEU LEU PRO LEU LEU HIS SEQRES 25 B 437 ARG ALA LEU HIS ALA GLN GLY ASP PRO ALA LEU SER MET SEQRES 26 B 437 SER HIS TRP MET PHE HIS GLN GLN ALA LEU GLN GLU TYR SEQRES 27 B 437 ILE LEU MET CYS CYS GLN CYS PRO ALA GLY GLY LEU LEU SEQRES 28 B 437 ASP LYS PRO GLY LYS SER ARG ASP PHE TYR HIS THR CYS SEQRES 29 B 437 TYR CYS LEU SER GLY LEU SER ILE ALA GLN HIS PHE GLY SEQRES 30 B 437 SER GLY ALA MET LEU HIS ASP VAL VAL LEU GLY VAL PRO SEQRES 31 B 437 GLU ASN ALA LEU GLN PRO THR HIS PRO VAL TYR ASN ILE SEQRES 32 B 437 GLY PRO ASP LYS VAL ILE GLN ALA THR THR TYR PHE LEU SEQRES 33 B 437 GLN LYS PRO VAL PRO GLY PHE GLU GLU LEU LYS ASP GLU SEQRES 34 B 437 THR SER ALA GLU PRO ALA THR ASP HET GLC C 1 11 HET FRU C 2 12 HET ED5 B 1 43 HET ZN B1001 1 HETNAM GLC ALPHA-D-GLUCOPYRANOSE HETNAM FRU BETA-D-FRUCTOFURANOSE HETNAM ED5 TERT-BUTYL 4-({(2-{(4-CYANOPHENYL)[(1-METHYL-1H- HETNAM 2 ED5 IMIDAZOL-5-YL)METHYL]AMINO}ETHYL)[(2-METHYLPHENYL) HETNAM 3 ED5 SULFONYL]AMINO}METHYL)PIPERIDINE-1-CARBOXYLATE HETNAM ZN ZINC ION HETSYN GLC ALPHA-D-GLUCOSE; D-GLUCOSE; GLUCOSE HETSYN FRU BETA-D-FRUCTOSE; D-FRUCTOSE; FRUCTOSE FORMUL 3 GLC C6 H12 O6 FORMUL 3 FRU C6 H12 O6 FORMUL 4 ED5 C32 H42 N6 O4 S FORMUL 5 ZN ZN 2+ FORMUL 6 HOH *729(H2 O) HELIX 1 1 LEU A 65 ALA A 73 5 9 HELIX 2 2 SER A 93 ASP A 110 1 18 HELIX 3 3 SER A 113 ASN A 127 1 15 HELIX 4 4 ASN A 130 LEU A 144 1 15 HELIX 5 5 ASP A 147 GLN A 162 1 16 HELIX 6 6 ASN A 165 ARG A 180 1 16 HELIX 7 7 GLN A 184 ASP A 196 1 13 HELIX 8 8 ASN A 199 LYS A 214 1 16 HELIX 9 9 ASN A 218 ASP A 230 1 13 HELIX 10 10 ASN A 233 THR A 247 1 15 HELIX 11 11 ASP A 252 VAL A 270 1 19 HELIX 12 12 ASN A 273 GLN A 285 1 13 HELIX 13 13 GLY A 288 LYS A 291 5 4 HELIX 14 14 TYR A 292 GLN A 303 1 12 HELIX 15 15 SER A 308 ASN A 325 1 18 HELIX 16 16 ASN A 329 GLU A 347 1 19 HELIX 17 17 ASP A 349 ILE A 351 5 3 HELIX 18 18 ARG A 352 SER A 368 1 17 HELIX 19 19 LEU B 25 ARG B 36 5 12 HELIX 20 20 THR B 44 SER B 63 1 20 HELIX 21 21 GLN B 76 ARG B 89 1 14 HELIX 22 22 THR B 92 ASP B 99 5 8 HELIX 23 23 SER B 101 LEU B 116 1 16 HELIX 24 24 PRO B 121 GLN B 136 1 16 HELIX 25 25 HIS B 151 GLY B 166 1 16 HELIX 26 26 THR B 167 ILE B 174 1 8 HELIX 27 27 ASN B 175 LYS B 187 1 13 HELIX 28 28 ASP B 202 THR B 216 1 15 HELIX 29 29 GLY B 226 GLN B 235 1 10 HELIX 30 30 HIS B 250 LYS B 265 1 16 HELIX 31 31 ARG B 266 LEU B 270 5 5 HELIX 32 32 ASN B 271 ARG B 282 1 12 HELIX 33 33 CYS B 301 GLN B 306 1 6 HELIX 34 34 GLY B 308 GLN B 320 1 13 HELIX 35 35 HIS B 333 CYS B 345 1 13 HELIX 36 36 ASP B 361 GLN B 376 1 16 HELIX 37 37 VAL B 391 ALA B 395 5 5 HELIX 38 38 GLY B 406 GLN B 419 1 14 SHEET 1 A 2 GLN A 89 ILE A 90 0 SHEET 2 A 2 GLN B 90 LEU B 91 1 O LEU B 91 N GLN A 89 SHEET 1 B 2 HIS B 377 SER B 380 0 SHEET 2 B 2 MET B 383 ASP B 386 -1 O MET B 383 N SER B 380 LINK C1 GLC C 1 O2 FRU C 2 1555 1555 1.42 LINK NBC ED5 B 1 ZN ZN B1001 1555 1555 2.04 LINK OD1 ASP B 299 ZN ZN B1001 1555 1555 2.10 LINK OD2 ASP B 299 ZN ZN B1001 1555 1555 2.40 LINK SG CYS B 301 ZN ZN B1001 1555 1555 2.30 LINK NE2 HIS B 364 ZN ZN B1001 1555 1555 2.10 CRYST1 178.386 178.386 64.510 90.00 90.00 120.00 P 61 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.005606 0.003237 0.000000 0.00000 SCALE2 0.000000 0.006473 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015501 0.00000